Morgan Stanley’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$111M Sell
6,613,553
-4,384,373
-40% -$73.5M 0.01% 1240
2025
Q1
$169M Sell
10,997,926
-3,913,193
-26% -$60.1M 0.01% 937
2024
Q4
$329M Buy
14,911,119
+1,355,226
+10% +$29.9M 0.02% 626
2024
Q3
$244M Buy
13,555,893
+416,691
+3% +$7.51M 0.02% 728
2024
Q2
$214M Buy
13,139,202
+7,713,582
+142% +$125M 0.02% 774
2024
Q1
$76.6M Sell
5,425,620
-11,024,540
-67% -$156M 0.01% 1378
2023
Q4
$172M Buy
16,450,160
+10,641,682
+183% +$111M 0.01% 1269
2023
Q3
$59.2M Sell
5,808,478
-1,141,312
-16% -$11.6M 0.01% 1419
2023
Q2
$52.3M Buy
6,949,790
+2,080,202
+43% +$15.7M 0.01% 1543
2023
Q1
$43.1M Sell
4,869,588
-1,424,405
-23% -$12.6M ﹤0.01% 1681
2022
Q4
$57.4M Buy
6,293,993
+465,489
+8% +$4.25M 0.01% 1386
2022
Q3
$47M Sell
5,828,504
-42,419
-0.7% -$342K 0.01% 1356
2022
Q2
$44.1M Buy
5,870,923
+1,993,556
+51% +$15M 0.01% 1470
2022
Q1
$36.4M Buy
3,877,367
+295,320
+8% +$2.77M ﹤0.01% 1533
2021
Q4
$28.7M Buy
3,582,047
+928,791
+35% +$7.44M ﹤0.01% 1789
2021
Q3
$25.8M Buy
2,653,256
+279,384
+12% +$2.72M ﹤0.01% 1818
2021
Q2
$23.5M Buy
2,373,872
+531,663
+29% +$5.26M ﹤0.01% 1984
2021
Q1
$21.3M Sell
1,842,209
-665,746
-27% -$7.68M ﹤0.01% 1850
2020
Q4
$24.2M Buy
2,507,955
+14,762
+0.6% +$142K ﹤0.01% 1626
2020
Q3
$22.5M Sell
2,493,193
-131,796
-5% -$1.19M ﹤0.01% 1392
2020
Q2
$32.4M Sell
2,624,989
-234,039
-8% -$2.89M 0.01% 1092
2020
Q1
$25.7M Sell
2,859,028
-2,732,117
-49% -$24.5M 0.01% 1112
2019
Q4
$54.8M Buy
5,591,145
+2,084,109
+59% +$20.4M 0.01% 872
2019
Q3
$24.1M Sell
3,507,036
-3,498,317
-50% -$24.1M 0.01% 1350
2019
Q2
$64.7M Buy
7,005,353
+5,140,764
+276% +$47.4M 0.02% 725
2019
Q1
$29.2M Buy
1,864,589
+290,110
+18% +$4.55M 0.01% 1168
2018
Q4
$24.3M Sell
1,574,479
-1,148,742
-42% -$17.7M 0.01% 1295
2018
Q3
$58.7M Sell
2,723,221
-1,836,111
-40% -$39.5M 0.01% 863
2018
Q2
$111M Buy
4,559,332
+729,283
+19% +$17.7M 0.03% 527
2018
Q1
$65.5M Sell
3,830,049
-2,593,449
-40% -$44.3M 0.02% 777
2017
Q4
$122M Buy
6,423,498
+230,685
+4% +$4.37M 0.03% 516
2017
Q3
$109M Sell
6,192,813
-819,573
-12% -$14.4M 0.03% 525
2017
Q2
$233M Sell
7,012,386
-1,491,530
-18% -$49.5M 0.07% 294
2017
Q1
$273M Buy
8,503,916
+1,302,307
+18% +$41.8M 0.08% 251
2016
Q4
$261M Sell
7,201,609
-1,536,705
-18% -$55.7M 0.09% 261
2016
Q3
$402M Buy
8,738,314
+5,935,210
+212% +$273M 0.14% 155
2016
Q2
$141M Sell
2,803,104
-226,850
-7% -$11.4M 0.05% 406
2016
Q1
$162M Buy
3,029,954
+1,416,525
+88% +$75.8M 0.06% 336
2015
Q4
$106M Buy
1,613,429
+15,631
+1% +$1.03M 0.04% 467
2015
Q3
$90.2M Sell
1,597,798
-499,766
-24% -$28.2M 0.03% 513
2015
Q2
$124M Sell
2,097,564
-106,352
-5% -$6.29M 0.04% 436
2015
Q1
$137M Buy
2,203,916
+475,332
+27% +$29.6M 0.05% 399
2014
Q4
$99.4M Sell
1,728,584
-243,391
-12% -$14M 0.04% 521
2014
Q3
$106M Buy
1,971,975
+204,458
+12% +$11M 0.04% 492
2014
Q2
$92.7M Buy
1,767,517
+35,675
+2% +$1.87M 0.04% 540
2014
Q1
$91.5M Sell
1,731,842
-1,002,438
-37% -$53M 0.04% 508
2013
Q4
$110M Buy
2,734,280
+304,759
+13% +$12.2M 0.05% 421
2013
Q3
$91.8M Buy
2,429,521
+43,777
+2% +$1.65M 0.04% 446
2013
Q2
$93.5M Buy
+2,385,744
New +$93.5M 0.05% 427